Market revenue in 2023 | USD 9.3 million |
Market revenue in 2030 | USD 22.1 million |
Growth rate | 13.2% (CAGR from 2023 to 2030) |
Largest segment | Product |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Product, Services |
Key market players worldwide | Thermo Fisher Scientific Inc, Illumina Inc, Qiagen NV, Abcam PLC, Takara Bio Inc, Revvity Inc, Maravai LifeSciences Holdings Inc Ordinary Shares - Class A, HTG Molecular Diagnostics Inc, Meridian Bioscience, New England Biolabs, Norgen Biotek, System Biosciences, Amoy Diagnostics, EntroGen |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mirna sequencing and assay market will help companies and investors design strategic landscapes.
Product was the largest segment with a revenue share of 80.65% in 2023. Horizon Databook has segmented the France mirna sequencing and assay market based on product, services covering the revenue growth of each sub-segment from 2018 to 2030.
The market in this country is expected to grow at a sustainable CAGR during the forecast period owing to technological advancements in miRNA sequencing and key player's initiative to create awareness about advanced technologies.
In December 2020, the French bioproduction sector launched an ambitious training platform Campus Biotech Digital. It is the first training platform in the world in the bioproduction sector, which will help develop skills in this field to meet new technological challenges. This platform is managed by a leading industrial consortium (bioMérieux, Novasep, Sanofi, & Servier).
Furthermore, government support and funding of research activities in the country are likely to boost the market in the coming years. For instance, in April 2020, the French government launched the Investing in the Future program (Investissements d'Avenir - PIA) to finance innovation and investments in France.
Horizon Databook provides a detailed overview of country-level data and insights on the France mirna sequencing and assay market , including forecasts for subscribers. This country databook contains high-level insights into France mirna sequencing and assay market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account